Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Otonomy Inc (OTIC)

Otonomy Inc (OTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Otonomy: Q3 Earnings Snapshot AP - Thu Nov 10, 2022

Otonomy: Q3 Earnings Snapshot

OTIC : 0.0085 (-92.64%)
Otonomy Reports Results from Phase 2 Clinical Trial of OTO-313 in Patients with Tinnitus Globe Newswire - Mon Aug 1, 2022

OTO-313 demonstrated no clinically meaningful improvement versus placebo for primary and secondary endpoints across all timepointsCompany to discontinue...

OTIC : 0.0085 (-92.64%)
Otonomy (OTIC) Q2 2022 Earnings Call Transcript Motley Fool - Mon Jul 25, 2022

OTIC earnings call for the period ending June 30, 2022.

OTIC : 0.0085 (-92.64%)
Otonomy Reports Second Quarter 2022 Financial Results and Provides Corporate Update Globe Newswire - Mon Jul 25, 2022

Top-line results for OTO-313 Phase 2 trial in tinnitus expected in August 2022; patient enrollment completed for clinical safety evaluation of higher and...

OTIC : 0.0085 (-92.64%)
Otonomy to Report Second Quarter 2022 Financial Results and Provide Corporate Update Globe Newswire - Mon Jul 18, 2022

SAN DIEGO, July 18, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative...

OTIC : 0.0085 (-92.64%)
Otonomy to Participate in the H.C. Wainwright Global Investment Conference Globe Newswire - Wed May 18, 2022

SAN DIEGO, May 18, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative...

OTIC : 0.0085 (-92.64%)
Otonomy Announces OTO-825 Presentation at the American Society of Gene & Cell Therapy Annual Meeting Globe Newswire - Thu May 12, 2022

SAN DIEGO, May 12, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative...

OTIC : 0.0085 (-92.64%)
Otonomy (OTIC) Q1 2022 Earnings Call Transcript Motley Fool - Mon May 9, 2022

OTIC earnings call for the period ending March 31, 2022.

OTIC : 0.0085 (-92.64%)
Otonomy Reports First Quarter 2022 Financial Results and Provides Corporate Update Globe Newswire - Mon May 9, 2022

Positive top-line results announced for OTO-413 Phase 2a in hearing loss; enrollment ongoing for higher dose evaluationOTO-313 Phase 2 trial in tinnitus...

OTIC : 0.0085 (-92.64%)
Otonomy to Report First Quarter 2022 Financial Results and Provide Corporate Update Globe Newswire - Mon May 2, 2022

SAN DIEGO, May 02, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative...

OTIC : 0.0085 (-92.64%)

Barchart Exclusives

3 Dividend Aristocrats to Buy on Every Dip Barchart - Wed Apr 24, 6:30PM CDT
As markets get wobbly, here are three Dividend Aristocrats to add a little stability to any portfolio. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot